Literature DB >> 15277519

Coordination of peroxisomal beta-oxidation and fatty acid elongation in HepG2 cells.

Derek A Wong1, Sara Bassilian, Shu Lim, Wai-Nang Paul Lee.   

Abstract

A major product of mitochondrial and peroxisomal beta-oxidation is acetyl-CoA, which is essential for multiple cellular processes. The relative role of peroxisomal beta-oxidation of long chain fatty acids and the fate of its oxidation products are poorly understood and are the subjects of our research. In this report we describe a study of beta-oxidation of palmitate and stearate using HepG2 cells cultured in the presence of multiple concentrations of [U-(13)C(18)]stearate or [U-(13)C(16)] palmitate. Using mass isotopomer analysis we determined the enrichments of acetyl-CoA used in de novo lipogenesis (cytosolic pool), in the tricarboxylic acid cycle (glutamate pool), and in chain elongation of stearate (peroxisomal pool). Cells treated with 0.1 mm [U-(13)C(18)]stearate had markedly disparate acetyl-CoA enrichments (1.1% cytosolic, 1.1% glutamate, 10.7% peroxisomal) with increased absolute levels of C20:0, C22:0, and C24:0. However, cells treated with 0.1 mm [U-(13)C(16)]palmitate had a lower peroxisomal enrichment (1.8% cytosolic, 1.6% glutamate, and 1.1% peroxisomal). At higher fatty acid concentrations, acetyl-CoA enrichments in these compartments were proportionally increased. Chain shortening and elongation was determined using spectral analysis. Chain shortening of stearate in peroxisomes generates acetyl-CoA, which is subsequently used in the chain elongation of a second stearate molecule to form very long chain fatty acids. Chain elongation of palmitate to stearate appeared to occur in a different compartment. Our results suggest that 1) chain elongation activity is a useful and novel probe for peroxisomal beta-oxidation and 2) chain shortening contributes a substantial fraction of the acetyl-CoA used for fatty acid elongation in HepG2 cells.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15277519     DOI: 10.1074/jbc.M406766200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  12 in total

1.  Virulence of Leishmania major in macrophages and mice requires the gluconeogenic enzyme fructose-1,6-bisphosphatase.

Authors:  Thomas Naderer; Miriam A Ellis; M Fleur Sernee; David P De Souza; Joan Curtis; Emanuela Handman; Malcolm J McConville
Journal:  Proc Natl Acad Sci U S A       Date:  2006-03-28       Impact factor: 11.205

2.  Characterizing phenotype with tracer based metabolomics.

Authors:  Wai Nang P Lee
Journal:  Metabolomics       Date:  2006-05-20       Impact factor: 4.290

Review 3.  Tracer-based metabolomics: concepts and practices.

Authors:  W-N Paul Lee; Paulin N Wahjudi; Jun Xu; Vay Liang Go
Journal:  Clin Biochem       Date:  2010-08-14       Impact factor: 3.281

4.  Compartmentalization of stearoyl-coenzyme A desaturase 1 activity in HepG2 cells.

Authors:  Jennifer K Yee; Catherine S Mao; Heidi S Hummel; Shu Lim; Sharon Sugano; Virender K Rehan; Gary Xiao; Wai-Nang Paul Lee
Journal:  J Lipid Res       Date:  2008-07-03       Impact factor: 5.922

5.  Fenofibrate simultaneously induces hepatic fatty acid oxidation, synthesis, and elongation in mice.

Authors:  Maaike H Oosterveer; Aldo Grefhorst; Theo H van Dijk; Rick Havinga; Bart Staels; Folkert Kuipers; Albert K Groen; Dirk-Jan Reijngoud
Journal:  J Biol Chem       Date:  2009-10-02       Impact factor: 5.157

6.  Identification of metabolites in the normal ovary and their transformation in primary and metastatic ovarian cancer.

Authors:  Miranda Y Fong; Jonathan McDunn; Sham S Kakar
Journal:  PLoS One       Date:  2011-05-19       Impact factor: 3.240

7.  Metabolic dysfunctions in multiple sclerosis: implications as to causation, early detection, and treatment, a case control study.

Authors:  Vijitha K Senanayake; Wei Jin; Asuka Mochizuki; Bassirou Chitou; Dayan B Goodenowe
Journal:  BMC Neurol       Date:  2015-08-27       Impact factor: 2.474

8.  PNU-91325 increases fatty acid synthesis from glucose and mitochondrial long chain fatty acid degradation: a comparative tracer-based metabolomics study with rosiglitazone and pioglitazone in HepG2 cells.

Authors:  George G Harrigan; Jerry Colca; Sándor Szalma; László G Boros
Journal:  Metabolomics       Date:  2006-05-18       Impact factor: 4.290

Review 9.  Mitochondrial Dysfunction in Cancer and Neurodegenerative Diseases: Spotlight on Fatty Acid Oxidation and Lipoperoxidation Products.

Authors:  Giuseppina Barrera; Fabrizio Gentile; Stefania Pizzimenti; Rosa Angela Canuto; Martina Daga; Alessia Arcaro; Giovanni Paolo Cetrangolo; Alessio Lepore; Carlo Ferretti; Chiara Dianzani; Giuliana Muzio
Journal:  Antioxidants (Basel)       Date:  2016-02-19

Review 10.  Neuronal Lipid Metabolism: Multiple Pathways Driving Functional Outcomes in Health and Disease.

Authors:  Timothy J Tracey; Frederik J Steyn; Ernst J Wolvetang; Shyuan T Ngo
Journal:  Front Mol Neurosci       Date:  2018-01-23       Impact factor: 5.639

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.